Submacular surgery for patients with age-related macular degeneration

Age-Related Macular Degeneration

Volumn , Issue , 2002, Pages 277-288

  Rao, P Kumar ^a   Thomas, Matthew A ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 16844375521     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (50)

1. De Juan E, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 1988;105:25-29.
2. Blinder KJ, Peyman GA, Paris CL, Gremillion CM. Submacular scar excision in age-related macular degeneration. Int Ophthalmol 1991;15:215-222.
3. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP Report 1. Arch Ophthalmol 1999;117:1329-1345.
4. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol 1990;108:825-831.
5. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1991;109:1232-1241.
6. Freund KB, Yannuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993;115:786-791.
7. Moisseiev JA, Masuri R, Treister G. The impact of the Macular Photocoagulation Study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol 1995;113:185-189.
8. Gass JD. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994; 118:285-298.
9. Grossniklaus HE, Gass JD. Clinicopathologic correlations of surgically excised type 1 and 2 type submacular choroidal neovascular membranes. Am J Ophthalmol 1998;126 (1):59-69.
10. Melberg NS, Thomas MA, Burgess DB. The surgical removal of subfoveal choroidal neovas-culariztion: Ingrowth site as a predictor of visual outcome. Retina 1996;16:190-195.
11. Ibanez HE, Thomas MA. Surgical approach to subfoveal neovascularization and submacular hemorrhage. Semin Ophthalmol 1994;9:56-64.
12. Giovannini A, Amato GP, Mariotti C, Scassellati-Sforzolini B. OCT Imaging of choroidal neovascularisation and its role in the determination of patients’ eligibility for surgery. Br J Ophthalmol 1999;83:438-442.
13. Giovannini A, Mariotti C, Scassellati-Sforzolini B, D’Altobrando E. Usefulness of fluorescein angiography in predicting the size of the atrophic area after surgical excision of choroidal neovascularization. Ophthalmologica 1999;213:139-144.
14. Thomas MA, Kaplan HJ. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol 1991;111:1-7.
15. Holekamp NM, Thomas MA, Dickinson JD, Valluri S. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: stability of early visual results. Ophthalmology 1997;104:22-26.
16. Thomas MA, Dickinson JD, Melberg NS, Ibanez HE, Dhaliwal RS. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 1994;101:1384-1396.
17. Loewenstein A, Sunness JS, Bressler NM, Marsh MJ, De Juan E. Scanning laser ophthalmoscope fundus perimetry after surgery for choroidal neovascularization. Am J Ophthalmol 1998;125(5):657-665.
18. Merrill PT, LoRusso FJ, Lomeo MD, Saxe SJ, Khan MM, Lambert HM. Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology 1999;106:782-789.
19. Roth DB, Downie AA, Charles ST. Visual results after submacular surgery for neovascularization in age-related macular degeneration. Ophthalm Surg Lasers 1997;28(11):920-925.
20. Thomas MA, Grand MG, Williams DF, Lee CF, Pesin SR, Lowe MA. Surgical management of subfoveal choroidal neovascularization. Ophthalmology 1992;99:952-968.
21. Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal neovascular membranes. Ophthalmology 1992; 99:969-976.
22. Lambert HM, Capone A, Aaberg T, Sternberg P, Mandell BA, Lopez PF. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 1991;113:257-262.
23. Green WR, Enger C. Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 1993;100:1519-1535.
24. Ormerod LD, Puklin JE, Frank RN. Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeration. Ophthalmology 1994;101:1201-1210.
25. Akduman L, Del Priore LV, Desai VN, Olk RJ, Kaplan HJ. Perfusion of the subfoveal chorio-capillaris affects visual recovery after submacular surgery in presumed ocular histoplasmosis syndrome. Am J Ophthalmol 1997;123(1):90-96.
26. Castellarin AA, Nasir M, Sugino IK, Zarbin MA. Progressive presumed choriocapillaris atrophy after surgery for age-related macular degeneration. Retina 1998;18(2):143-149.
27. Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 1990;109:33-37.
28. Berrocal MH, Lewis ML, Flynn HW. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 1996;122:486-493.
29. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal hemorrhage in age-related macular degeneration. Retina 1996;16:183-189.
30. Ibanez HE, Williams DF, Thomas MA, Ruby AJ, Meredith TA, Boniuk I, et al. Surgical management of submacular hemorrhage: a series of 47 consecutive cases. Arch Ophthalmol 1995;113:62-69.
31. Lewis H. Intraoperative fibriolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1999;118:559-568.
32. Lim JI, Drews-Botsch C, Sternberg P Jr, Capone A, Aaberg TM. Submacular hemorrhage removal. Ophthalmology 1995;102:1393-1399.
33. Kamei M, Tano Y, Maeno T, Mitsuda H, Yuasa T. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 1996;121:267-275.
34. Hochman MA, Seery CM, Zarbin MA. Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmol 1997;42:195-213.
35. Petersen J, Meyer-Riemann W, Ritzau-Tondrow U, Bahlmann D. Visual fields after removal of subretinal hemorrhages and neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1998;236:241-247.
36. Submacular Surgery Trials Pilot Study Investigators. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. I. Ophthalmic outcomes, Submacular Surgery Trials Pilot Study report number 1. Am J Ophthalmol 2000;130(4):387-407.
37. Submacular Surgery Trials Pilot Study Investigators. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration. II. Quality of life outcomes, Submacular Surgery Trials Pilot Study report number 2. Am J Ophthalmol 2000;130(4): 408-418.
38. Oslen TW, Capone A, Sternberg P, Grossniklaus H, Martin DF, Aaberg TM. Subfoveal choroidal neovascularization in punctate inner choroidopathy: surgical management and pathologic findings. Ophthalmology 1996;103:2061-2069.
39. Adelberg DA, Del Priore LV, Kaplan HJ. Surgery for subfoveal membranes in myopia, angioid streaks and other disorders. Retina 1995;15:198-205.
40. Bottoni F, Perego E, Airaghi P, Cigada M, Ortolina S, Carlevaro G, et al. Surgical removal of subfoveal choroidal neovascular membranes in high myopia. Graefes Arch Clin Exp Ophthalmol 1999; 237(7):573-582.
41. Chen CJ, Urban LL, Nelson NC, Fratkin JD. Surgical removal of subfoveal iatrogenic choroidal neovascular membranes. Ophthalmology 1998;105(9):1606-1611.
42. Berger AS, Conway M, Del Priore LV, Walker RS., Pollack JS, Kaplan HJ. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. Arch Ophthalmol 1997;115:991-996.
43. Berger AS, McCuen BW, Brown GC, Brownlow RL. Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Retina 1997;17 (2): 94-98.
44. Sears J, Capone A, Aaberg T, Lewis H, Grossniklaus H, Sternberg P, et al. Surgical management of subfoveal neovascularization in children. Ophthalmology 1999;106(5):920-924.
45. Uemura A, Thomas MA. Visual outcome after surgical removal of choroidal neovascularizaion in pediatric patients. Arch Ophthalmol 2000;118:1373-1378.
46. Joseph DP, Thomas MA. Surgical treatment of juxtafoveal choroidal neovascularization. Invest Ophthalmol Vis Res 1997;38 (Suppl):457.
47. Atebara NH, Thomas MA, Holekamp NM, Mandell BA, Del Priore LV. Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome. Ophthalmology 1998;105(6):1598-1605.
48. Benson MT, Callear A, Tsaloumas M, Chhina J, Beatty S. Surgical excision of subfoveal neovascular membranes. Eye 1998; 12:768-774.
49. Melberg NS, Thomas MA, Dickinson JD, Valluri S. Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome. Ophthalmology 1996;103:1064-1068.
50. Loewenstein A, Rader RS, Shelley TH, De Juan E. A flexible infusion micro-cannula for subretinal surgery. Ophthalm Surg Lasers 1997;28(9):774-775.